NASDAQ:MLAB

Mesa Laboratories (MLAB) Stock Forecast, Price & News

$106.90

-3.26 (-2.96%)

(As of 09/27/2023 ET)

Compare

Today's Range: $106.53
▼
$110.50
50-Day Range: $110.16
▼
$143.36
52-Week Range: $106.53
▼
$206.36

Volume: 41,564 shs
Average Volume: 48,226 shs
Market Capitalization: $575.12 million

P/E Ratio: 323.95
Dividend Yield: 0.60%
Price Target: $166.00

Mesa Laboratories MarketRank™ Forecast

Analyst Rating: 0.00 Rating Score
Upside/Downside: 55.3% Upside
$166.00 Price Target
Short Interest: Bearish
6.61% of Shares Sold Short
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: N/A
Insider Trading: Selling Shares
$779,340 Sold Last Quarter
Proj. Earnings Growth: -8.64%
From $5.67 to $5.18 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.51 out of 5 stars

Medical Sector

917th out of 976 stocks

Process Control Instruments Industry

11th out of 11 stocks

2.0

Analyst's Opinion

Price Target Upside/Downside
According to analysts' consensus price target of $166.00, Mesa Laboratories has a forecasted upside of 55.3% from its current price of $106.90.
Amount of Analyst Coverage
Mesa Laboratories has received no research coverage in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
6.61% of the outstanding shares of Mesa Laboratories have been sold short.
Short Interest Ratio / Days to Cover
Mesa Laboratories has a short interest ratio ("days to cover") of 10.5, which indicates bearish sentiment.
Change versus previous month
Short interest in Mesa Laboratories has recently decreased by 1.82%, indicating that investor sentiment is improving.

0.8

Dividend Strength

Dividend Yield
Mesa Laboratories has a dividend yield of 0.57%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Mesa Laboratories does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Mesa Laboratories is 193.95%. Payout ratios above 75% are not desirable because they may not be sustainable.
Dividend Sustainability
Based on earnings estimates, Mesa Laboratories will have a dividend payout ratio of 12.36% next year. This indicates that Mesa Laboratories will be able to sustain or increase its dividend.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for MLAB.

3.3

News and Social Media Coverage

News Sentiment
Mesa Laboratories has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.84 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 1 news article for Mesa Laboratories this week, compared to 2 articles on an average week.
Search Interest
Only 1 people have searched for MLAB on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
MarketBeat Follows
3 people have added Mesa Laboratories to their MarketBeat watchlist in the last 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Mesa Laboratories insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $779,340.00 in company stock.
Percentage Held by Insiders
Only 5.20% of the stock of Mesa Laboratories is held by insiders.
Percentage Held by Institutions
91.06% of the stock of Mesa Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.0

Earnings and Valuation

Earnings Growth
Earnings for Mesa Laboratories are expected to decrease by -8.64% in the coming year, from $5.67 to $5.18 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Mesa Laboratories is 323.95, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 119.95.
Price to Earnings Ratio vs. Sector
The P/E ratio of Mesa Laboratories is 323.95, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 118.04.
Price to Book Value per Share Ratio
Mesa Laboratories has a P/B Ratio of 1.45. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Mesa Laboratories (NASDAQ:MLAB) Stock

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. The Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in various therapeutic areas, such as screenings for hereditary diseases, pharmacogenetics, and oncology related applications. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enable customers to automate chemical synthesis of peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The Calibration Solutions segment designs, manufactures, and markets quality control products to measure or calibrate temperature, pressure, pH, and humidity for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

MLAB Price History

30 days | 90 days | 365 days | Advanced Chart

MLAB Stock News Headlines

September 15, 2023 | finance.yahoo.com

Insider Sell: Director John Schmieder Sells 3,000 Shares of Mesa Laboratories Inc

September 14, 2023 | finance.yahoo.com

MLAB: Lowering target price to $102.00

September 27, 2023 | Chaikin Analytics (Ad)

Buy This Stock for AI Tidal Wave (not NVDA)

The internet boom made more millionaires than any tech - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.

September 13, 2023 | finance.yahoo.com

Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2023

August 24, 2023 | finance.yahoo.com

Mesa Laboratories, Inc. Announces Commitment to Disclose Scope 1 and 2 Greenhouse Gas Emissions

August 23, 2023 | seekingalpha.com

Mesa Laboratories: Continued Pressure On Equity Re-Rating, Reiterate Hold

August 21, 2023 | seekingalpha.com

Mesa Laboratories (MLAB) Investor Presentation - Slideshow

August 10, 2023 | finance.yahoo.com

Here’s Why Mesa Laboratories (MLAB) Declined in Q2

September 27, 2023 | Behind the Markets (Ad)

Laser breakthrough could send stock soaring 2,467%

Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...

August 3, 2023 | finance.yahoo.com

Mesa Labs (MLAB) Surpasses Q1 Earnings Estimates

July 31, 2023 | finance.yahoo.com

Mesa Laboratories, Inc.'s (NASDAQ:MLAB) Intrinsic Value Is Potentially 32% Above Its Share Price

July 6, 2023 | msn.com

Mesa Laboratories (MLAB) Price Target Decreased by 11.27% to 160.65

June 26, 2023 | benzinga.com

President and CEO at Mesa Laboratories Acquires Company Stock Options Worth 17,896 Shares

June 26, 2023 | benzinga.com

CFO at Mesa Laboratories Acquires Company Stock Options Worth 5,619 Shares

June 21, 2023 | finance.yahoo.com

Mesa Laboratories, Inc. to Announce First Quarter Results on August 3, 2023

June 8, 2023 | msn.com

Mesa Laboratories: No Economic Earnings At 18x EBIT Is A Tough Ask

May 25, 2023 | finanznachrichten.de

Mesa Laboratories, Inc.: Mesa Labs Announces Unaudited Fourth Quarter and Full Fiscal Year 2023 Results

May 25, 2023 | finance.yahoo.com

Mesa Labs (MLAB) Q4 Earnings and Revenues Miss Estimates

May 25, 2023 | finance.yahoo.com

Mesa Labs Announces Unaudited Fourth Quarter and Full Fiscal Year 2023 Results

May 24, 2023 | msn.com

Mesa Laboratories's Earnings Outlook

May 22, 2023 | finance.yahoo.com

Investor Optimism Abounds Mesa Laboratories, Inc. (NASDAQ:MLAB) But Growth Is Lacking

May 2, 2023 | finance.yahoo.com

Mesa Laboratories (NASDAQ:MLAB) Is Reinvesting At Lower Rates Of Return

April 5, 2023 | msn.com

Mesa Laboratories (MLAB) Declares $0.16 Dividend

April 3, 2023 | finance.yahoo.com

Mesa Labs (MLAB) Stock Sinks As Market Gains: What You Should Know

April 3, 2023 | finance.yahoo.com

Investors in Mesa Laboratories (NASDAQ:MLAB) have unfortunately lost 33% over the last year

March 13, 2023 | finance.yahoo.com

Mesa Laboratories, Inc. Reports Immaterial Financial Exposure to Silicon Valley Bank Closure

March 9, 2023 | finance.yahoo.com

Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year 2023 Results on May 25, 2023

See More Headlines

Receive MLAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter.

MLAB Company Calendar

Last Earnings: 8/03/2023
Ex-Dividend for 9/15 Dividend: 8/30/2023
Dividend Payable: 9/15/2023
Today: 9/27/2023
Next Earnings (Confirmed): 11/06/2023
Fiscal Year End: 3/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Process control instruments
Sub-Industry: Electronic Equipment & Instruments
Sector: Medical
Current Symbol: NASDAQ:MLAB
CUSIP: 59064R10
CIK: 724004
Web: www.mesalabs.com
Phone: (303) 987-8000
Fax: 303-987-8989
Employees: 698
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $166.00
High Stock Price Forecast: $166.00
Low Stock Price Forecast: $166.00
Forecasted Upside/Downside: +53.7%
Consensus Rating
Rating Score (0-4): 0.00
Research Coverage: 0 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.33
Trailing P/E Ratio: 327.28
Forward P/E Ratio: 19.05
P/E Growth: N/A
Net Income: $930,000.00
Net Margins: 0.83%
Pretax Margin: 1.86%
Return on Equity: 9.36%
Return on Assets: 5.50%

Debt

Debt-to-Equity Ratio: 0.45
Current Ratio: 2.93
Quick Ratio: 2.03

Sales & Book Value

Annual Sales: $219.08 million
Price / Sales: 2.65
Cash Flow: $11.43 per share
Price / Cash Flow: 9.45
Book Value: $73.60 per share
Price / Book: 1.47

Miscellaneous

Outstanding Shares: 5,380,000
Free Float: 5,104,000
Market Cap: $581.04 million
Optionable: Not Optionable
Beta: 0.72

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Mr. Gary M. Owens (Age 55)
CEO, Pres & Director
Comp: $1.02M

Mr. John V. Sakys (Age 54)
VP, CFO & Chief Accounting Officer
Comp: $551.4k

Mr. Brian David Archbold (Age 47)
Sr. VP of Continuous Improvement
Comp: $485.59k

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

MLAB Stock - Frequently Asked Questions

What is Mesa Laboratories' stock price forecast for 2023?: 0 analysts have issued twelve-month target prices for Mesa Laboratories' shares. Their MLAB share price forecasts range from $166.00 to $166.00. On average, they expect the company's stock price to reach $166.00 in the next twelve months. This suggests a possible upside of 53.7% from the stock's current price.
View analysts price targets for MLAB or view top-rated stocks among Wall Street analysts.
How have MLAB shares performed in 2023?: Mesa Laboratories' stock was trading at $166.21 at the beginning of 2023. Since then, MLAB stock has decreased by 35.0% and is now trading at $108.00.
View the best growth stocks for 2023 here.
When is Mesa Laboratories' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, November 6th 2023.
View our MLAB earnings forecast.
How were Mesa Laboratories' earnings last quarter?: Mesa Laboratories, Inc. (NASDAQ:MLAB) released its earnings results on Thursday, August, 3rd. The medical instruments supplier reported $1.22 EPS for the quarter, topping the consensus estimate of $1.13 by $0.09. The medical instruments supplier earned $50.65 million during the quarter, compared to analysts' expectations of $51.85 million. Mesa Laboratories had a trailing twelve-month return on equity of 9.36% and a net margin of 0.83%.
How often does Mesa Laboratories pay dividends? What is the dividend yield for Mesa Laboratories?: Mesa Laboratories announced a quarterly dividend on Wednesday, July 5th. Stockholders of record on Thursday, August 31st will be paid a dividend of $0.16 per share on Friday, September 15th. This represents a $0.64 annualized dividend and a dividend yield of 0.59%. The ex-dividend date of this dividend is Wednesday, August 30th.
Read our dividend analysis for MLAB.
What ETFs hold Mesa Laboratories' stock?: ETFs with the largest weight of Mesa Laboratories (NASDAQ:MLAB) stock in their portfolio include MFAM Small-Cap Growth ETF (MFMS).Motley Fool Small-Cap Growth ETF (TMFS).
Is Mesa Laboratories a good dividend stock?: Mesa Laboratories (NASDAQ:MLAB) pays an annual dividend of $0.64 per share and currently has a dividend yield of 0.57%. The dividend payout ratio is 193.95%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, MLAB will have a dividend payout ratio of 12.36% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MLAB.
What is Gary Owens' approval rating as Mesa Laboratories' CEO?: 5 employees have rated Mesa Laboratories Chief Executive Officer Gary Owens on Glassdoor.com. Gary Owens has an approval rating of 51% among the company's employees. This puts Gary Owens in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Mesa Laboratories own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Mesa Laboratories investors own include NVIDIA (NVDA), Verizon Communications (VZ), Intel (INTC), Alibaba Group (BABA), Altria Group (MO), Micron Technology (MU), Exxon Mobil (XOM), AbbVie (ABBV), Advanced Micro Devices (AMD) and Becton, Dickinson and Company (BDX).
What is Mesa Laboratories' stock symbol?: Mesa Laboratories trades on the NASDAQ under the ticker symbol "MLAB."
Who are Mesa Laboratories' major shareholders?: Mesa Laboratories' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (15.17%), Conestoga Capital Advisors LLC (10.71%), Ranger Investment Management L.P. (4.33%), Geneva Capital Management LLC (3.56%), State Street Corp (3.35%) and Royce & Associates LP (2.97%). Insiders that own company stock include Brian David Archbold, David M Kelly, Evan Guillemin, Gary M Owens, Gregory Dinoia, John Bradley Schmieder, John James Sullivan, John Sakys and Shannon Hall.
View institutional ownership trends.
How do I buy shares of Mesa Laboratories?: Shares of MLAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Mesa Laboratories' stock price today?: One share of MLAB stock can currently be purchased for approximately $108.00.
How much money does Mesa Laboratories make?: Mesa Laboratories (NASDAQ:MLAB) has a market capitalization of $581.04 million and generates $219.08 million in revenue each year. The medical instruments supplier earns $930,000.00 in net income (profit) each year or $0.33 on an earnings per share basis.
How many employees does Mesa Laboratories have?: The company employs 698 workers across the globe.
How can I contact Mesa Laboratories?: Mesa Laboratories' mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The official website for the company is www.mesalabs.com. The medical instruments supplier can be reached via phone at (303) 987-8000, via email at investorrelations@mesalabs.com, or via fax at 303-987-8989.

This page (NASDAQ:MLAB) was last updated on 9/27/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial